Evidence map›Paper›PMID 28235099›Full record

Observational studyPloS one2017

The natural killer cell response to West Nile virus in young and old individuals with or without a prior history of infection.

Yi Yao, Dara M Strauss-Albee, Julian Q Zhou, Anna Malawista, Melissa N Garcia, Kristy O Murray, Catherine A Blish, Ruth R Montgomery

Abstract readObservational Study
In one paragraph

Observational study in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. West Nile virus unmasked: from gene variability to future challenges.Frontiers in cellular and infection microbiology · 2025
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Natural killer cells in antiviral immunity.Nature reviews. Immunology · 2022
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yi YaoDepartment of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America.
Dara M Strauss-AlbeeStanford Immunology, Stanford University School of Medicine, Stanford, California, United States of America.
Julian Q ZhouDepartment of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America.
Anna MalawistaDepartment of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America.
Melissa N GarciaDepartment of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, United States of America.
Kristy O MurrayDepartment of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, United States of America.
Catherine A BlishStanford Immunology, Stanford University School of Medicine, Stanford, California, United States of America.
Ruth R MontgomeryDepartment of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America.ORCID http://orcid.org/0000-0002-8661-4454

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Systems investigation of vaccine responses in B cell depleted autoimmune patientsU19AI089992 · NIAID · YALE UNIVERSITY · PI David A. Hafler, RUTH R MONTGOMERY · 2010 to 2026
$50.4M
Yale Study Support Suite (YES3): Dashboard and Web Portal Software Supporting Research Workflow through integrated, customizable REDCap External ModulesP30AG021342 · NIA · YALE UNIVERSITY · PI Denise Esserman · 2002 to 2026
$37.9M
Modeling the influence of sex on natural killer cell networksDP2AI112193 · NIAID · STANFORD UNIVERSITY · PI BLISH, CATHERINE A · 2013 to 2015
$2.5M
Renal And Neurological Outcomes In Chronically Infected West Nile Virus PatientsR01AI091816 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MURRAY, KRISTY · 2011 to 2014
$1.5M
Defining the Natural Killer Cell Response to HIVF31AI118469 · NIAID · STANFORD UNIVERSITY · PI STRAUSS-ALBEE, DARA · 2015 to 2015
$43k
NCATS NIH HHS UL1 TR001863NIAID NIH HHS DP2 AI112193NIAID NIH HHS F31 AI118469NIAID NIH HHS HHSN272201100019CNIAID NIH HHS HHSN272201100019INIAID NIH HHS R01 AI091816NIAID NIH HHS U19 AI089992NIA NIH HHS P30 AG021342
6 · The paper itself

Abstract

West Nile virus (WNV) typically leads to asymptomatic infection but can cause severe neuroinvasive disease or death, particularly in the elderly. Innate NK cells play a critical role in antiviral defenses, yet their role in human WNV infection is poorly defined. Here we demonstrate that NK cells mount a robust, polyfunctional response to WNV characterized by cytolytic activity, cytokine and chemokine secretion. This is associated with downregulation of activating NK cell receptors and upregulation of NK cell activating ligands for NKG2D. The NK cell response did not differ between young and old WNV-naïve subjects, but a history of symptomatic infection is associated with more IFN-γ producing NK cell subsets and a significant decline in a specific NK cell subset. This NK repertoire skewing could either contribute to or follow heightened immune pathogenesis from WNV infection, and suggests that NK cells could play an important role in WNV infection in humans.

Indexed as

Immunity, InnateAdultAgedAged, 80 and overAge FactorsAntigens, CDAsymptomatic DiseasesFemaleGene Expression RegulationHumansImmunophenotypingInterferon-gammaKiller Cells, NaturalLymphocyte ActivationLymphocyte CountMiddle AgedAntigens, CDInterferon-gammaKLRK1 protein, humanNatural Cytotoxicity Triggering Receptor 1Natural Cytotoxicity Triggering Receptor 2Natural Cytotoxicity Triggering Receptor 3NCR1 protein, humanNCR2 protein, humanNCR3 protein, humanNK Cell Lectin-Like Receptor Subfamily CNK Cell Lectin-Like Receptor Subfamily K

Identifiers

PMID28235099
PMCPMC5325267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.